BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

You Can Knock-Out a Gene, But Can You Win the Match? Come and Find Out at the AmorChem l.p. KNOCK-OUT™ Event at Biocontact 2013 and You Could Qualify for an Amorchem Financing!


8/2/2013 1:20:48 PM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

August 2, 2013 -- Inspired by the popular television show “DRAGONS’ DEN”, AmorChem is hosting its first KNOCK-OUT Event at BioContact 2013, in Québec City. Researchers chosen to participate in the AmorChem KNOCK-OUT Event will fight it out in the ring against our panel of “Heavyweights” (seasoned biotech executives, all still standing, unbeaten after many rounds in the biotech arena), and you could be granted an AmorChem financing of up to $500,000.

If you are an academic life science researcher with an appetite to knock-out the competition, if you have innovative science with strong commercial potential, then you may be one of the participants chosen to duke it out in the AmorChem KNOCK-OUT Event.

Interested researchers must fill out the attached form describing their technology, its clinical applications, its relevance to human disease, as well as its commercial potential. As competition in the ring will be fierce, researchers are encouraged to seek the assistance of their technology transfer or commercialization office that can also prove useful in training for the final Event.

All application forms must be submitted no later than Friday, September 4th, 2013, at 8 pm at the following email address: info@amorchem.com

Participants chosen to bump fists in the final round will be notified no later than September 16th, 2013. They will then become Contenders in the Amorchem KNOCK-OUT Event and will be invited to a final “weigh-in” in the form of a conference call in order to assist them in their final preparations.

Contenders will then convene on October 2nd at the “AmorChem” session of BioContact 2013 in Québec City. Note that all Contenders must register for the conference in order to participate in the AmorChem KNOCK-OUT Event.

The Event will play out in front of a live audience. At the sound of the bell, each Contender will be given up to five minutes to make their case on their technology. Following their pitch, each Contender will duke it out, in the ring, with our “Heavyweights” over a seven minute Q&A “boxing match”. The Contenders will confront the “Heavyweights” with only wits and scientific agility in their corner. Just as boxers climb into the ring with only their gloves, our contenders will not be allowed visual support.

The champion of this first Québec edition of the AmorChem KNOCK-OUT Event may qualify for a financing of up to $500,000 from AmorChem, subject to completion of final pre-investment conditions including approval by the AmorChem Investment Committee. All Contenders will be invited to a dinner in Québec City with our “Heavyweights” following the Event.

Can you roll with the punches, and go 5 rounds in the ring with our seasoned biotech executives? If you think you can, act fast: spaces will be limited to a maximum of 7 participants and the deadline for application is September 4th, 2013!

ABOUT AMORCHEM

AmorChem (www.amorchem.com) is a venture capital fund located in Montreal focused on investing in promising life science projects originating from Quebec-based universities and research centres. AmorChem’s innovative business model involves financing research-stage projects to enable them to reach pre-clinical proof-of-concept (POC) in a semi-virtual mode within 18-24 months. The fund seeks to generate returns through a two-pronged exit strategy: sell projects having reached POC to large biotechnology or pharmaceutical companies; or bundle them into new spin-out companies. Projects are managed by AmorChem using a combination of the resources found in the researcher’s lab, other academic labs and contract research organisations. In order to contribute efficiently to projects requiring small molecules, AmorChem established its own medicinal chemistry contract research organisation- NuChem Therapeutics Inc.

ABOUT BIOCONTACT 2013:

http://www.biocontact.qc.ca/english/

ABOUT NUCHEM THERAPEUTICS:

www.nuchemtherapeutics.com

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES